ACCEPTANCE OF COVID-19 VACCINE AMONG THE RESIDENTS OF KARACHI, PAKISTAN
DOI:
https://doi.org/10.52764/jms.22.30.4.16Keywords:
acceptance, concern, Pakistan, Corona virus, VaccineAbstract
Objectives: This study aimed to evaluate the acceptance of the coronavirus vaccine and the attitude of people residing in the southern part of Karachi, Pakistan.
Methods: This web-based cross-sectional research was conducted among the citizens of the southern part of Karachi from Oct to Dec 2021. The survey for the study was adopted and modified from the formerly conducted study by El-Elimat et al, comprising individuals aged more than 18 years of age. Acceptance and predictors of vaccine acceptance were assessed using the Chi-square test and Binary logistic regression.
Results: The acceptance rate for the coronavirus vaccine was quite high (87%). Males demonstrated a higher acceptance rate. The older aged individuals (>35 years old) also showed higher acceptance when likened to younger participants (OR = 1.84, 95 CI% = 2.893–1.171, p < .008). Individuals not infected with COVID-19 showed less acceptance towards vaccinations (OR = 0.431, 95CI% = 0.233– 0.799, p < .008). Similarly, respondents believing the COVID-19 vaccine to be a conspiracy were less likely to show acceptance towards the vaccination process (OR= 0.893, 95 CI% = 0.575- 1.387, p= 0. 614).
Conclusion: Differences in the acceptance rate between males of older age as compared to younger population and females have demonstrated higher acceptance towards vaccination. Sinopharm followed by Sinovac was the most frequently used to provide immunization to the Pakistani population.
Keywords: adverse effects, immunology, Coronavirus, Vaccine
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
